Open AccessRheumatoid arthritis patients show different levels of pro-inflammatory chemokine-cleaving enzyme CD26 on T cells, depending on the therapy
Author(s) -
Oscar J. Cordero,
Calvio Cristina,
Varela Rubn,
Lpez-Gonzlez Tania,
Vinuela Juan,
Mourio Coral,
De Aspe De La Iglesia Bruno,
Rodrguez-Lpez Marina,
Del Campo-Prez Victor,
Pego Jos
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.01018
Subject(s) - dipeptidyl peptidase , medicine , rheumatoid arthritis , chemokine , proinflammatory cytokine , immune system , immunology , stromal cell , arthritis , ccl5 , t cell , inflammation , enzyme , biology , biochemistry , il 2 receptor